鈣蛋白酶1(CAPN1)活性蛋白
Active Calpain 1 (CAPN1)
PIG30; CANPL1; MuCANP; MuCL; Calpain 1, Large Subunit; Calpain-1 Catalytic Subunit; Calcium-Dependent Protease 1; Calcium-activated neutral proteinase 1; Calpain mu-type; Micromolar-calpain
- 編號(hào)APB964Hu01
- 物種Homo sapiens (Human,人) 相同的名稱(chēng),不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)5.5
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1632 ¥ 4080 ¥ 8160 ¥ 24480 ¥ 61200
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
活性實(shí)驗(yàn)
Calpain 1 (CAPN1), a calcium-dependent cysteine protease, is a member of the calpain family. CAPN1 is primarily found in muscle tissue, particularly in skeletal muscle, where it is involved in the regulation of muscle contraction and relaxation.It is involved in various physiological and pathological processes, such as apoptosis, cell signal transduction and cytoskeleton reconstruction. It is reported that the binding of BID and CAPN1 plays an important role in the process of apoptosis. Thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human CAPN1 and recombinant human BID. Briefly, CAPN1 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to BID-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-CAPN1 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μL stop solution to the wells and read at 450/630 nm immediately. The binding activity of recombinant human CAPN1 and recombinant human BID was shown in Figure 1, the EC50?for this effect is 0.1 ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPB964Hu02 | 鈣蛋白酶1(CAPN1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB964Hu01 | 鈣蛋白酶1(CAPN1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB964Hu01 | 鈣蛋白酶1(CAPN1)活性蛋白 | Cell?culture;?Activity?Assays. |
APB964Hu02 | 鈣蛋白酶1(CAPN1)活性蛋白 | Cell?culture;?Activity?Assays. |
PAB964Hu01 | 鈣蛋白酶1(CAPN1)多克隆抗體 | WB; IHC |
PAB964Hu02 | 鈣蛋白酶1(CAPN1)多克隆抗體 | WB; IHC; ICC; IP. |
LAB964Hu71 | 鈣蛋白酶1(CAPN1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAB964Hu22 | 鈣蛋白酶1(CAPN1)單克隆抗體 | WB; IHC; ICC; IP. |
SEB964Hu | 鈣蛋白酶1(CAPN1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB964Hu | 鈣蛋白酶1(CAPN1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Bulletin du?Cancer | Calpain 1 in bronchoalveolar lavage fluid is associated with poor prognosis in lepidic predominant pulmonary adenocarcinoma [Pubmed: 30683309] |